A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Cornell, R. F.; Locke, F. L.; Bishop, M. R.; Orlowski, R. Z.; Larson, S. M.; Borrello, I.; Giralt, S.; Kumar, S.; Nooka, A. K.; Raje, N. S.; Rossi, J. M.; Thomrongsith, L.; Xue, A.; Roberts, Z. |
| Abstract Title: | A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 161s |
| Language: | English |
| ACCESSION: | WOS:000442916007570 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS3103 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS3103 -- Source: Wos |
